JP2002525313A5 - - Google Patents

Download PDF

Info

Publication number
JP2002525313A5
JP2002525313A5 JP2000571896A JP2000571896A JP2002525313A5 JP 2002525313 A5 JP2002525313 A5 JP 2002525313A5 JP 2000571896 A JP2000571896 A JP 2000571896A JP 2000571896 A JP2000571896 A JP 2000571896A JP 2002525313 A5 JP2002525313 A5 JP 2002525313A5
Authority
JP
Japan
Prior art keywords
weight
enteric
composition
water
flake material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000571896A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002525313A (ja
JP4662634B2 (ja
Filing date
Publication date
Priority claimed from US09/162,282 external-priority patent/US6139875A/en
Application filed filed Critical
Publication of JP2002525313A publication Critical patent/JP2002525313A/ja
Publication of JP2002525313A5 publication Critical patent/JP2002525313A5/ja
Application granted granted Critical
Publication of JP4662634B2 publication Critical patent/JP4662634B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000571896A 1998-09-29 1999-09-13 胃透過性の低い水性腸溶性被覆組成物 Expired - Fee Related JP4662634B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/162,282 1998-09-29
US09/162,282 US6139875A (en) 1998-09-29 1998-09-29 Aqueous enteric coating composition and low gastric permeability enteric coating
PCT/US1999/021072 WO2000018376A1 (en) 1998-09-29 1999-09-13 Aqueous enteric coating composition with low gastric permeability

Publications (3)

Publication Number Publication Date
JP2002525313A JP2002525313A (ja) 2002-08-13
JP2002525313A5 true JP2002525313A5 (enExample) 2006-11-24
JP4662634B2 JP4662634B2 (ja) 2011-03-30

Family

ID=22584979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000571896A Expired - Fee Related JP4662634B2 (ja) 1998-09-29 1999-09-13 胃透過性の低い水性腸溶性被覆組成物

Country Status (5)

Country Link
US (1) US6139875A (enExample)
EP (1) EP1117385B1 (enExample)
JP (1) JP4662634B2 (enExample)
DE (1) DE69928555T2 (enExample)
WO (1) WO2000018376A1 (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
KR100461566B1 (ko) * 2001-11-15 2004-12-14 삼성정밀화학 주식회사 수계 분산 히드록시프로필메틸 셀룰로오스 프탈레이트나노입자의 제조방법
SE0103839D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Pharmaceutical formulation & product
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
KR100511086B1 (ko) * 2003-09-17 2005-08-30 삼성정밀화학 주식회사 장용성의 수계 분산 히드록시프로필 메틸셀룰로오스프탈레이트 나노입자의 제조방법
KR20050080626A (ko) * 2004-02-10 2005-08-17 삼성정밀화학 주식회사 수계분산 히드록시프로필 메틸셀룰로오스 프탈레이트나노입자 조성물의 제조방법
PE20060003A1 (es) 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
EP1778196A4 (en) * 2004-07-26 2008-12-17 Teva Pharma PHARMACEUTICAL DOSAGES CONTAINING RASAGILINE
WO2007016563A2 (en) * 2005-08-01 2007-02-08 Alpharma Inc. Alcohol resistant pharmaceutical formulations
ES2567595T3 (es) * 2005-10-12 2016-04-25 Opko Renal, Llc Métodos y artículos para tratar la insuficiencia y la deficiencia de 25-hidroxivitamina D
US20070092559A1 (en) * 2005-10-24 2007-04-26 Jinghua Yuan Liquid dosage forms having enteric properties of delayed and then sustained release
DK1993559T3 (en) 2006-02-03 2016-10-03 Opko Renal Llc Treatment of vitamin D deficiency and MALFUNCTION with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US8329677B2 (en) 2006-06-21 2012-12-11 Cytochroma, Inc. Method of treating and preventing secondary hyperparathyroidism
US8968799B2 (en) * 2006-09-01 2015-03-03 Rise-N-Shine L.L.C. Time delayed release mechanism for energizing composition and method of use
FI3225243T3 (fi) 2007-04-25 2025-10-13 Opko Renal Llc Menetelmä sekundaarisen hyperparatyreoosin turvalliseen ja tehokkaaseen hoitoon ja ehkäisyyn kroonisen munuaistaudin yhteydessä
WO2009047644A2 (en) * 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
EP2148685A4 (en) * 2007-04-25 2010-07-28 Cytochroma Inc METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
DK2481400T3 (da) 2007-04-25 2014-09-29 Opko Ip Holdings Ii Inc Orale præparater med kontrolleret frigivelse omfattende en vitamin D-forbindelse og en voksagtig bærer
ES2593356T3 (es) 2008-04-02 2016-12-07 Opko Ireland Global Holdings, Ltd. Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
JP2012518635A (ja) 2009-02-24 2012-08-16 リター ファーマシューティカルズ インコーポレイテッド プレバイオティック製剤および使用方法
WO2011032169A2 (en) * 2009-09-14 2011-03-17 Phusis Therapeutics Inc. Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
US20110217426A1 (en) * 2010-03-04 2011-09-08 Perry Stephen C Enteric coating composition
EP3636280B1 (en) 2010-03-29 2025-05-14 EirGen Pharma Ltd. Methods and compositions for reducing parathyroid levels
WO2014093988A2 (en) 2012-12-14 2014-06-19 Phusis Therapeutics, Inc. Methods and compositions for inhibiting cnksr1
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
WO2015153841A1 (en) 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
WO2016172191A1 (en) 2015-04-20 2016-10-27 Phusis Therapeutics, Inc. Compounds, compositions and methods for inhibiting cnksr1
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US20160331689A1 (en) 2015-05-12 2016-11-17 SE Tylose USA, Inc. Aqueous enteric coating composition
WO2017066134A1 (en) * 2015-10-16 2017-04-20 Merck Sharp & Dohme Corp. Processes for preparing formulations for gastrointestinal-targeted therapies
JP6895961B2 (ja) 2015-11-03 2021-06-30 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． 食物アレルギーの処置および／または防止のための治療用微生物叢
MX395229B (es) 2016-03-28 2025-03-21 Opko Ireland Global Holdings Ltd Métodos de tratamiento con vitamina d.
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3473245A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
EP3473244A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
AU2018365877A1 (en) 2017-11-10 2020-05-28 Nutrition & Biosciences USA 4, Inc. Unique morphological polysaccharide
CN111936570A (zh) 2017-12-14 2020-11-13 杜邦工业生物科学美国有限责任公司 α-1，3-葡聚糖接枝共聚物
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
FR3083545A1 (fr) 2018-07-04 2020-01-10 Institut National De La Recherche Agronomique Utilisation d'une souche de roseburia intestinalis pour la prevention et le traitement de l'inflammation de l'intestin
EP3846830A4 (en) 2018-09-05 2022-07-06 Solarea Bio, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
WO2020086935A1 (en) 2018-10-25 2020-04-30 Dupont Industrial Biosciences Usa, Llc Alpha-1,3-glucan graft copolymers
CA3116415A1 (en) 2018-11-05 2020-05-14 MarvelBiome, Inc. Microbial compositions comprising ellagitannin and methods of use
CA3143713A1 (en) 2019-06-19 2020-12-24 Solarea Bio, Inc. Microbial compositions and methods for producing upgraded probiotic assemblages
CA3159763A1 (en) 2019-11-06 2021-05-14 Nutrition & Biosciences USA 4, Inc. Highly crystalline alpha-1,3-glucan
US11733011B2 (en) * 2020-11-24 2023-08-22 Raytheon Company Steering system with power take-off from actuators
WO2023092150A1 (en) 2021-11-22 2023-05-25 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
WO2025064621A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating colorectal cancer
WO2025064645A1 (en) 2023-09-19 2025-03-27 Flagship Pioneering Innovations Vi, Llc Compositions and methods for treating inflammatory bowel disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150111A (en) * 1974-05-28 1979-04-17 Allister Warren Enteric coated magnesium chloride
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
US5026559A (en) * 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
US5104922A (en) * 1990-10-22 1992-04-14 E. I. Du Pont De Nemours And Company Stable aqueous aluminum flake dispersion
JP2925346B2 (ja) * 1991-03-18 1999-07-28 田辺製薬株式会社 腸溶性製剤およびその製法
WO1995016451A1 (fr) * 1992-06-22 1995-06-22 Franck Arno Gouchet Comprimes a liberation controlee de 4-asa
US5330759A (en) * 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
JPH08109126A (ja) * 1994-10-07 1996-04-30 Amano Pharmaceut Co Ltd 耐衝撃性腸溶性顆粒剤およびこれを含有する錠剤
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5612397A (en) * 1994-12-19 1997-03-18 Rohm And Haas Company Composition having wet state clarity
JPH08245423A (ja) * 1995-03-06 1996-09-24 Shionogi & Co Ltd 水系腸溶性コーティング液
JPH08333240A (ja) * 1995-06-02 1996-12-17 Shin Etsu Chem Co Ltd 粉末またはペレット状ワックスを用いる無溶媒腸溶性コーティング剤で被覆した腸溶性製剤
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
US5756008A (en) * 1996-08-14 1998-05-26 E. I. Du Pont De Nemours And Company Water cleanable silver composition

Similar Documents

Publication Publication Date Title
JP2002525313A5 (enExample)
JP4662634B2 (ja) 胃透過性の低い水性腸溶性被覆組成物
Dashevsky et al. Physicochemical and release properties of pellets coated with Kollicoat® SR 30 D, a new aqueous polyvinyl acetate dispersion for extended release
AU781707B2 (en) Oral pharmaceutical forms of administration with a delayed action
US5508044A (en) Diltiazem pharmaceutical spheroid formulation
Siepmann et al. Blends of aqueous polymer dispersions used for pellet coating: importance of the particle size
JP4381479B2 (ja) ジルチアゼム除放性製剤
CN102215827B (zh) 基于微粒的耐酒精缓释口服药物剂型
JP2007510677A (ja) 調節性の物質の放出に影響を及ぼすマトリックスを有する多層の剤形
JP5847303B2 (ja) 医薬品剤形又は機能性食品剤形に適したコーティング組成物
Junyaprasert et al. Release profile comparison and stability of diltiazem–resin microcapsules in sustained release suspensions
JP2005162750A (ja) 延長された放出抑制性を有するオピオイド製剤
JPS56127322A (en) Enteric coating material composition for solid drug
US20080254115A1 (en) Micropellet Containing Pellets and Method of Preparing Such Pellets
NL8901200A (nl) Langwerkend diclofenacnatriumpreparaat.
DK153520B (da) Overtrukket farmaceutisk tablet med forlaenget afgivelse og fremgangsmaade til fremstilling heraf
Kilor et al. Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using κ-carrageenan as a pelletizing agent
EP0559645A1 (en) Composition for solid pharmaceutical preparations containing active vitamins d 3? and process for preparation thereof
CN1956707B (zh) 包含n-(2-(2-苯二酰亚氨基乙氧基)-乙酰基)-l-丙氨酰基-d-谷氨酸(lk-423)的耐胃酸的药物剂型
JPS6335527A (ja) 被覆性イオン交換樹脂
JP2004505034A (ja) 制御された放出のシグモイドパターンを示すエレトリプタンの粒状組成物
CN1972674B (zh) 多层形式的药物
Alhnan et al. Inhibiting the gastric burst release of drugs from enteric microparticles: the influence of drug molecular mass and solubility
Osterwald Properties of film-formers and their use in aqueous systems
Zhai et al. Gastroretentive extended-release floating granules prepared using a novel fluidized hot melt granulation (FHMG) technique